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Obesity: a certain and avoidable cause of cancer
Body-mass index (BMI) is a simple and commonly 
used measurement in clinical medicine and 
population health—a ratio of weight (kilogrammes) 
and height (metres squared). Adults with a BMI of 
25–29·9 kg/m² are considered overweight and adults 
with a BMI of 30 kg/m² or higher are considered 
obese. The causes and consequences of overweight 
and obesity, however, are anything but simple. 
Determinants of BMI include genetic and epigenetic 
factors; individual behaviours (eg, physical activity, 
sedentary time, and caloric intake); sociocultural factors; 
and the physical, economic, and policy environments. 
Excess adipose tissue is not a benign storage depot for 
lipids.1 Indeed, overweight and obesity were estimated 
to cause 3·4 million deaths worldwide in 2010.2 The 
proportion of adults who were overweight or obese 
worldwide increased markedly from 1980 to 2013, with 
parallel increases in children and adolescents.3 Although 
the causes of these disturbing trends are multifactorial, 
they almost certainly include the wide propagation of 
cheap, calorically dense, and nutritionally poor food and 
drink.4,5 The well-established associations between high 
BMI and increased morbidity include coronary heart 
disease, type 2 diabetes, high blood pressure, stroke, 
dyslipidaemia, and osteoarthritis. Studies published 
during the last two decades have added certain cancers 
to this list.6,7
In The Lancet, Krishnan Bhaskaran and colleagues8 add 
further supportive evidence that high BMI is associated 
with risk of many speciﬁ c types of cancer. Although 
numerous studies have examined associations between 
BMI and risk of individual cancers, this broad and 
comprehensive study illustrates the full cancer incidence 
burden that is imposed by high BMI. Using data from 
the UK’s Clinical Practice Research Datalink (CPRD), the 
authors identiﬁ ed 5·24 million persons, from an initial 
cohort of 10 million, with suﬃ  cient BMI and follow-up 
time for analysis. All 5·24 million individuals were thought 
to be cancer-free at the onset of analysis. After a mean 
observation period of 7·5 years, over 166 000 people 
developed one of the 22 cancers of interest to the authors, 
which represent about 90% of all cancers diagnosed in 
the UK. Each 5 kg/m² increase in BMI was associated with 
higher risks of cancers of the uterus (hazard ratio [HR] 
1·62, 99% CI 1·56–1·69), gallbladder (1·31, 1·12–1·52), 
kidney (1·25, 1·17–1·33), liver (1·19, 1·12–1·27), colon 
(1·10, 1·07–1·13), cervix (1·10, 1·03–1·17), thyroid (1·09, 
1·00–1·19), ovary (1·09, 1·04–1·14), postmenopausal 
breast (1·05, 1·03–1·07), pancreas (1·05, 1·00–1·10), 
and rectum (1·04, 1·00–1·08), and of leukaemia (1·09, 
1·05–1·13). More detailed analyses revealed associations 
between BMI and cancers of the oesophagus, pancreas, 
and stomach in non-smokers; associations with liver, 
colon, ovarian, and breast cancers were modiﬁ ed by other 
factors (eg, sex and menopausal status). Higher BMI was 
associated with lower risk of prostate and premenopausal 
breast cancers. Inverse associations between BMI 
and cancers of the oral cavity and lung were null after 
restricting analyses to never smokers, suggesting 
confounding by smoking dose.
Importantly, beyond measuring relative risks, the 
authors assessed measures of population eﬀ ect. Of the 
ten cancer sites associated with BMI in categorical models, 
overweight and obese BMI was estimated to account for 
between 2% (thyroid) and 41% (uterus) of these cancers 
in the UK. Additionally, the authors estimate that a 
population-wide 1 kg/m² increase in BMI would cause an 
additional 3790 cancer diagnoses in the UK each year.
Conﬁ dence in these results is bolstered by the authors’ 
many sensitivity and model checking exercises. The 
message from these additional analyses is that the main 
study results were not aﬀ ected by obvious analytical 
decisions by the authors or confounding. Conﬁ dence in 
the study is further strengthened by the fact that nearly 
all of these ﬁ ndings have been reported in previous 
studies; a notable exception includes the study’s ﬁ nding 
of higher risk of cervical cancer with high BMI. 
There are a few caveats to Bhaskaran and colleagues’ 
study that should be mentioned. Selection bias might be 
a strong threat to validity in this study; in particular, only 
slightly more than 50% of the initial cohort had suﬃ  cient 
BMI data and follow-up time for analysis. If BMI is more 
likely to be measured in people with comorbidities or 
medical conditions that are also associated with cancer 
risk (eg, type 2 diabetes or gallstones) then some bias 
might be present. The lack of histological, molecular 
phenotype, and cancer sub-site speciﬁ c data for many 
of the cancers in this study is a serious limitation, as 
acknowledged by the authors. This is especially true 
when interpreting the results for oesophageal cancer 
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Reducing the global prevalence of overweight and obesity
The issues associated with weight gain beyond the 
proper capacity of human physiology and associated 
health consequences are well understood.1 Together 
with the technological revolution in food science and 
the sale of junk food, modern lifestyles and increasing 
disposable income play a part in this problem. 
Although appetite is necessary for survival, increased 
exposure to processed food is overwhelming people,2 
and eﬀ ective strategies to reduce body-mass index 
(BMI) in populations are scarce. Understanding this 
situation, so that acceptable remedial action can be 
properly discussed and implemented, should be an 
essential part of public health policy in the next few 
decades.
Public health eﬀ orts are leading to progress in tobacco 
control and cardioprotective diets in a slow and deliberate 
way. As a result, deaths caused by smoking-related 
diseases and cardiovascular diseases are decreasing, 
at least in developed countries, although rises in BMI 
threaten these trends.3 Can a similar success with weight 
ever happen? Does the whole food environment, not just 
dietary fat and tobacco, need to be changed to reduce 
exposure to calories, in circumstances in which economic 
growth, via consumption, is deemed to be of prime 
importance? An appropriate rebalancing of the primal 
needs of humans with food availability is essential, which 
would entail curtailing many aspects of production and 
marketing for food industries.4,5 To prevent unsustainable 
where a clear link is established between BMI and 
oesophageal adenocarcinomas, and a possible inverse 
association has been shown for oesophageal squamous 
cell carcinomas.9 The authors included in this analysis 
persons with exceptionally low BMI values (<15 kg/m²), 
which sometimes hinders interpretation of the data 
because exceedingly low BMI values probably represent 
data recording errors or extreme illness.
We have suﬃ  cient evidence that obesity is an important 
cause of unnecessary suﬀ ering and death from many 
forms of cancer,6,7,10 in addition to the well recognised 
increased risks of mortality and morbidity from many 
other causes. More research is not needed to justify, 
or even demand, policy changes aimed at curbing 
overweight and obesity. Some of these policy strategies 
have been enumerated recently,11 all of which focus on 
reducing caloric intake or increasing physical activity, and 
include taxes on calorically dense, nutritionally sparse 
foods (eg, sugar-sweetened beverages); subsidies for 
healthier foods, especially in economically disadvantaged 
groups; agricultural policy changes; and urban planning 
aimed at encouraging walking and other modes of 
physical activity. Research strategies that identify 
population-wide or community-based interventions 
and policies that eﬀ ectively reduce overweight and 
obesity should be particularly encouraged and supported. 
Moreover, we need a political environment, and 
politicians with suﬃ  cient courage, to implement such 
policies eﬀ ectively. 
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